Quick Answer
ORAGENICS INC reported Diluted EPS of $4.56 per share (loss) for fiscal year 2025.
ORAGENICS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$4.56 | +90.5% |
| 2024 | -$47.88 | -421.6% |
| 2023 | -$9.18 | -29.1% |
| 2022 | -$7.11 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.96 | +82.7% | +36.8% |
| June 30, 2025 | -$3.10 | +79.7% | -2483.3% |
| March 31, 2025 | -$0.12 | +82.9% | +98.9% |
| September 30, 2024 | -$11.32 | -1231.8% | +25.9% |
| June 30, 2024 | -$15.27 | -911.3% | -2081.4% |
| March 31, 2024 | -$0.70 | +50.4% | +17.6% |
| September 30, 2023 | -$0.85 | +57.3% | +43.7% |
| June 30, 2023 | -$1.51 | +18.4% | -7.1% |
- ORAGENICS INC showed an increase of +90.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, ORAGENICS INC’s diluted eps has grown by 35.9% (from $7.11 per share (loss) to $4.56 per share (loss)).
- The most recent figure is from ORAGENICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: